Company overview
PT Etana Biotechnologies Indonesia
Name
PT Etana Biotechnologies Indonesia
Entity type
PT (Limited Liability Company)
Address
Jl. Rawa Gelam V Blk L Kav. 11-13, Kel. Jatinegara, Kec. Cakung
Postal code
13930
Country
Indonesia
Primary goods traded
- 💉57.0% — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products (300241)
- 💉18.8% — Blood, human or animal, antisera, other blood fractions and immunological products (300215)
- 💉11.1% — Blood, human or animal, antisera, other blood fractions and immunological products (300212)
- 7.3% — Machinery (842230)
- 5.8% — Blood, human or animal, antisera, other blood fractions and immunological products (300213)
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| Yuxi Walvax Biotechnology Co., Ltd. | seller | $15,605,863 | 31.20% |
| Walvax Biotechnology Co., Ltd. | seller | $1,618,433 | 3.24% |
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 30 July 2024 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,931,625.50 | |
| 10 September 2025 | ID | 30024190 | Ready To Fill Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (Crm197/Tt) | PT Etana Biotechnologies Indonesia | ID | Cansino Biologics Inc. | $1,653,761.53 | |
| 29 December 2023 | ID | 30024190 | Bulk 13-Valent Pneumococcal Polysaccharide Conjugate | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,597,494.68 | |
| 1 September 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,579,467.78 | |
| 30 September 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | CN | $1,558,306.86 |
| 1 August 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,557,827.04 | |
| 2 June 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,516,334.16 | |
| 16 April 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,313,763.00 | |
| 26 June 2024 | ID | 30021500 | Bevacizumab Injection 4Ml/Vial (1 Vial/Box) | PT Etana Biotechnologies Indonesia | ID | Innovent Biologics Suzhou Company Limited | $1,275,000.00 | |
| 11 September 2025 | ID | 30024190 | Ready To Fill Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (Crm197/Tt) | PT Etana Biotechnologies Indonesia | ID | Cansino Biologics Inc. | $1,231,179.99 |
0 of 20 row(s) selected.